Amegadzie JEmil, Gorgui J, Acheampong L, Gamble J-M, Farrell J, Gao Z. Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma-COPD overlap: a systematic review and meta-analysis. J Asthma. 2019;:1-16.

Alwashmi MF, Fitzpatrick B, Davis E, Farrell J, Gamble J-M, Hawboldt J. Therapeutic Advances in Respiratory Disease. Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85090365197&partnerID=MN8TOARS

Alwashmi MF, Fitzpatrick B, Farrell J, Gamble J-M, Davis E, van Nguyen H, et al. JMIR mHealth and uHealth. Perceptions of patients regarding mobile health interventions for the management of chronic obstructive pulmonary disease: Mixed methods study [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85088678572&partnerID=MN8TOARS

Alwashmi MF, Fitzpatrick B, Davis E, Gamble J-M, Farrell J, Hawboldt J. JMIR mHealth and uHealth. Perceptions of health care providers regarding a mobile health intervention to manage chronic obstructive pulmonary disease: Qualitative study [Internet]. 2019;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85070540885&partnerID=MN8TOARS

Alwashmi MF, Fitzpatrick B, Davis E, Gamble J-M, Farrell J, Hawboldt J. Perceptions of Health Care Providers Regarding a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative Study. JMIR Mhealth Uhealth. 2019;7(6):e13950.

Alwashmi M, Hawboldt J, Davis E, Marra C, Gamble J-M, Ashour WA. JMIR mHealth and uHealth. The effect of smartphone interventions on patients with chronic obstructive pulmonary disease exacerbations: A systematic review and meta-analysis [Internet]. 2016;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85019981382&partnerID=MN8TOARS

Alkabbani W, Maxwell CJ, Marrie RAnn, Tyas SL, Lega IC, Gamble J‐M. Diabetes, Obesity and Metabolism. Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities [Internet]. 2024;Available from: https://doi.org/10.1111/dom.15385

Alkabbani W, Gamble J-M. Journal of Pharmaceutical Health Services Research. Trends in estimated total retail dispensed prescriptions of purported COVID-19 treatments and preventions in Canada [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85163707017&partnerID=MN8TOARS

Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble J-M. International Journal of Epidemiology. Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85147424628&partnerID=MN8TOARS

Alkabbani W, Shah BR, Zongo A, Eurich DT, Alsabbagh MW, Gamble J-M. Diabetes, Obesity and Metabolism. Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85167588605&partnerID=MN8TOARS

Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble J-M. Diabetes Care. Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85165521395&partnerID=MN8TOARS

Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble J-M. Diabetes Care. Associations of Mid-and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85147047452&partnerID=MN8TOARS

Alkabbani W, Gamble J-M. Canadian Journal of Diabetes. Prescribing Trends of the Sodium–Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015–2021) [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85143981743&partnerID=MN8TOARS

Alkabbani W, Gamble J-M. British Journal of Clinical Pharmacology. Active-comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85124712639&partnerID=MN8TOARS

Alkabbani W, Pelletier R, Beazely MA, Labib Y, Quan B, Gamble J-M. Drug Safety. Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85125655701&partnerID=MN8TOARS

Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, et al. Diabetic Medicine. Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85129462097&partnerID=MN8TOARS

Alkabbani W, Gamble J-M, Eurich DT, Minhas-Sandhu JK, Shah BR, Alsabbagh MW, et al. Diabetes and Metabolism. Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85120915534&partnerID=MN8TOARS

Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, et al. Canadian Journal of Diabetes. Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85129507933&partnerID=MN8TOARS

Alkabbani W, Gamble J-M, Eurich DT, Minhas-Sandhu JK, Shah BR, Alsabbagh MWasem, et al. Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. DIABETES & METABOLISM. 2022;48:101305.

Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MWasem, et al. Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus. DIABETIC MEDICINE. 2022;39:e14858.